CompuMed Announces Changes in Management and Board of Directors

Nov 04, 2015, 09:00 ET from CompuMed

LOS ANGELES, November 4, 2015 /PRNewswire/ --

CompuMed, Inc. (OTCPink: CMPD), the leader in providing Enterprise Telemedicine Solutions, announced today that W. Scott Rombach has resigned as President, CEO, and Director of CompuMed, Inc., effective November 13, 2015. Lee Keddie and David Pointer, existing CompuMed Directors, will serve in the role of interim Co-CEOs for the company.

Additionally, Board Members Jeremy Weiner and Daniel McCarthy have resigned from the Board of Directors. Benjamin Large, Lee Keddie and David Pointer will remain as Directors.

"The CompuMed Board hired me to lead the company through its turnaround phase, which began approximately three years ago. CompuMed has posted its best operating results in recent history. I'm proud to say that the company is well positioned to begin the next phase of its evolution," said W. Scott Rombach, CompuMed's President and CEO.

"CompuMed is excited to have someone of Lee's caliber and experience to step into this role as interim CEO. In addition, I look forward to working in partnership with him, as CompuMed continues to grow in the field of telemedicine," stated David Pointer, CompuMed's Chairman.

"Over the past two years as a consultant to the Company and later as a Board Member, I have been impressed with the hardworking team of dedicated CompuMed employees and I look forward to expanding upon the blueprint for success that has been developed for the company under Scott's leadership," Lee added.

Lee Keddie brings engineering and executive experience to CompuMed, including expertise in developing scalable systems. He was the President and General Manager of HKX Inc., where company revenues increased by eight times during his 14-year tenure. HKX provided hydraulic system kits within the construction equipment market and was sold to Diploma PLC. Mr. Keddie also spent eight years working as an Aerospace Engineer for a number of companies within the aeronautical field, including McDonnell Douglas and Boeing. He received a degree in Mechanical Engineering from the University of Waterloo.

David Pointer has been a board member since December of 2013. Mr. Pointer is the Managing Partner and Founder of VI Capital Management, LLC, a value investment fund. Mr. Pointer is a Chartered Financial Analyst (CFA), graduated from Central Washington University and received his MBA from The Wharton School of Business.

About CompuMed, Inc. 

CompuMed, Inc. (OTCPink: CMPD) Enterprise Telemedicine Solutions provide patients with the highest level of clinical care at reduced costs. Its telecardiology and teleradiology offerings provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities anywhere in the world. The company has been in business over 26 years and services over 1,000 clinical settings. CompuMed is headquartered in Los Angeles, CA. Visit CompuMed at

Forward-Looking Statements  

Statements contained in this report, such as statements about revenue, operations, and earnings growth and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including statements concerning the Company's plans, objectives, expectations and intentions are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are subject to uncertainties and risks including, without limitation, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission and OTC Pink operated by OTCMarkets. All such forward-looking statements are expressly qualified by these cautionary statements. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.

CompuMed, Inc.
Investor Relations,
+1-(310)-258-5000 x117